Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Thompson-Leduc

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Managed Care & Specialty Pharmacy|September 15, 2025
Cost-per-responder analysis of daratumumab, bortezomib, lenalidomide, and dexamethasone vs bortezomib, lenalidomide, and dexamethasone among transplant-eligible patients with newly diagnosed multiple myelomaSantosh Gautam, Laura Morrison, Philippe Thompson-Leduc, et al.
Current Medical Research and Opinion|March 9, 2021
Outcomes and resource use of patients with large hemispheric infarction and cerebral edema: analysis of real-world dataShih-Yin Chen, Philippe Thompson-Leduc, Robert N Sawyer, et al.
BMC Cancer|December 3, 2021
Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review studyShebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, et al.
BMC Cancer|November 13, 2021
Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review studyShebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, et al.
The Journal of Rheumatology|March 1, 2024
Dr Singer et al replyDavid Singer, Philippe Thompson-Leduc, Sara Poston, et al.
The Journal of Rheumatology|February 1, 2023
Incidence of Herpes Zoster in Patients With Rheumatoid Arthritis in the United States: A Retrospective Cohort StudyDavid Singer, Philippe Thompson-Leduc, Sara Poston, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2022
Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma initiating daratumumab: A real-world chart review studyShebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, et al.
Orphanet Journal of Rare Diseases|May 20, 2026
Real-world treatment patterns and clinical burden of patients with hereditary angioedema treated with long-term prophylaxisWilliam Lumry, Art Zbrozek, Philippe Thompson-Leduc, et al.
The Clinical Respiratory Journal|November 23, 2022
Chronic obstructive pulmonary disease is associated with an increased risk of herpes zoster: A retrospective United States claims database analysisPhilippe Thompson-Leduc, Parinaz Ghaswalla, Wendy Y Cheng, et al.
Critical Care Medicine|December 23, 2017
Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-AnalysisIrena Iankova, Philippe Thompson-Leduc, Noam Y Kirson, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Managed Care & Specialty Pharmacy|September 15, 2025
Cost-per-responder analysis of daratumumab, bortezomib, lenalidomide, and dexamethasone vs bortezomib, lenalidomide, and dexamethasone among transplant-eligible patients with newly diagnosed multiple myelomaSantosh Gautam, Laura Morrison, Philippe Thompson-Leduc, et al.
Current Medical Research and Opinion|March 9, 2021
Outcomes and resource use of patients with large hemispheric infarction and cerebral edema: analysis of real-world dataShih-Yin Chen, Philippe Thompson-Leduc, Robert N Sawyer, et al.
BMC Cancer|December 3, 2021
Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review studyShebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, et al.
BMC Cancer|November 13, 2021
Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review studyShebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, et al.
The Journal of Rheumatology|March 1, 2024
Dr Singer et al replyDavid Singer, Philippe Thompson-Leduc, Sara Poston, et al.
The Journal of Rheumatology|February 1, 2023
Incidence of Herpes Zoster in Patients With Rheumatoid Arthritis in the United States: A Retrospective Cohort StudyDavid Singer, Philippe Thompson-Leduc, Sara Poston, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2022
Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma initiating daratumumab: A real-world chart review studyShebli Atrash, Philippe Thompson-Leduc, Ming-Hui Tai, et al.
Orphanet Journal of Rare Diseases|May 20, 2026
Real-world treatment patterns and clinical burden of patients with hereditary angioedema treated with long-term prophylaxisWilliam Lumry, Art Zbrozek, Philippe Thompson-Leduc, et al.
The Clinical Respiratory Journal|November 23, 2022
Chronic obstructive pulmonary disease is associated with an increased risk of herpes zoster: A retrospective United States claims database analysisPhilippe Thompson-Leduc, Parinaz Ghaswalla, Wendy Y Cheng, et al.
Critical Care Medicine|December 23, 2017
Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-AnalysisIrena Iankova, Philippe Thompson-Leduc, Noam Y Kirson, et al.
Pageof 5